All Stories

  1. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons
  2. A Peptide Link Between Human Cytomegalovirus Infection, Neuronal Migration, and Psychosis
  3. Epitopes for a 2019-nCoV vaccine
  4. Herpesviruses, autoimmunity and epilepsy: Peptide sharing and potential cross-reactivity with human synaptic proteins
  5. Cross-Reactivity as a Mechanism Linking Infections to Stroke
  6. Cytomegalovirus Infection: The Neurodevelopmental Peptide Signatures
  7. Peptide Sharing Between Viruses and DLX Proteins: A Potential Cross-Reactivity Pathway to Neuropsychiatric Disorders
  8. Efficacy of intensive aphasia therapy in patients with chronic stroke: a randomised controlled trial
  9. The Guillain–Barrè peptide signatures: from Zika virus to Campylobacter, and beyond
  10. Communicative-Pragmatic Assessment Is Sensitive and Time-Effective in Measuring the Outcome of Aphasia Therapy
  11. From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between Toxoplasma gondii and N-Methyl-d-Aspartate Receptors As a Potential Mechanistic Link
  12. Electrophysiological Evidence for Early and Interactive Symbol Access and Rule Processing in Retrieving and Combining Language Constructions
  13. A Spiking Neurocomputational Model of High-Frequency Oscillatory Brain Responses to Words and Pseudowords
  14. Therapy-Induced Neuroplasticity of Language in Chronic Post Stroke Aphasia: A Mismatch Negativity Study of (A)Grammatical and Meaningful/less Mini-Constructions
  15. Using language for social interaction: Communication mechanisms promote recovery from chronic non-fluent aphasia
  16. Minimal immune determinants connect Zika virus, human Cytomegalovirus, andToxoplasma gondiito microcephaly-related human proteins
  17. Reply concerning the article “Zika virus and autoimmunity: From microcephaly to Guillain–Barré syndrome, and beyond”
  18. Zika virus and autoimmunity: From microcephaly to Guillain-Barré syndrome, and beyond
  19. Understanding Neuropsychiatric Diseases, Analyzing the Peptide Sharing between Infectious Agents and the Language-Associated NMDA 2A Protein
  20. Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B
  21. H1N1 versus H5N1 hemagglutinins: A possible differential immunologic impact on neurodevelopment
  22. EBV-Associated Cancer and Autoimmunity: Searching for Therapies
  23. Single Amino Acid Repeats Connect Viruses to Neurodegeneration
  24. The Peptide Network between Tetanus Toxin and Human Proteins Associated with Epilepsy
  25. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
  26. Predictors and dynamics of postpartum relapses in women with multiple sclerosis
  27. Peptide matching between Epstein-Barr virus and human proteins
  28. Peptide profiling of the route from Mahoney to Sabin, and return
  29. Peptide Sharing Between Influenza A H1N1 Hemagglutinin and Human Axon Guidance Proteins
  30. Confronting JC virus and Homo sapiens biological signatures 
  31. West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses
  32. Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis
  33. Increasing age at disability milestones among MS patients in the MSBase Registry
  34. Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome
  35. A peptide talk between JC virus and the human host: from silent infection to autoimmunity
  36. Impact of Natalizumab on Cognitive Performances and Fatigue in Relapsing Multiple Sclerosis: A Prospective, Open-Label, Two Years Observational Study
  37. Developing an anti-Campylobacter jejunivaccine
  38. Circumscribing the Conformational Peptide Epitope Landscape
  39. How a single amino acid change may alter the immunological information of a peptide
  40. The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry
  41. The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude
  42. Treating multiple sclerosis with natalizumab
  43. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone
  44. Natural History of Multiple Sclerosis: Have Available Therapies Impacted Long-Term Prognosis?
  45. Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide
  46. Charting the peptide crossreactome between HIV-1 and the human proteome
  47. No human protein is exempt from bacterial motifs, not even one
  48. Proposing Low-Similarity Peptide Vaccines againstMycobacterium tuberculosis
  49. Bacterial peptides are intensively present throughout the human proteome
  50. Proteome-guided search for influenza A B-cell epitopes
  51. Massive peptide sharing between viral and human proteomes
  52. Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response
  53. Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes
  54. Sub-epitopic dissection of HCV E1315–328HRMAWDMMMNWSPT sequence by similarity analysis
  55. Peptidology: short amino acid modules in cell biology and immunology
  56. Identification of Monoclonal Anti-HMW-MAA Antibody Linear Peptide Epitope by Proteomic Database Mining
  57. NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope
  58. Non-self-discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients
  59. Clinical applications of DNA microarray analysis